Cite

HARVARD Citation

    Doorduijn, J. et al. (n.d.). P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY. HemaSphere. pp. 1062-1063. [Online]. 
  
Back to record